Pharmaceuticals & Biotechnology (4570)

26,449.37
   
  • 52 Week High: 26,550.57
  • 52 Week Low: 18,687.04

Latest ShareCast News

Oxford Biomedica confirms takeover approach from PE firm EQT

By Michele Maatouk

Date: Wednesday 14 Jan 2026

(Sharecast News) - Oxford Biomedica confirmed on Wednesday that it has received unsolicited takeover approaches from private equity firm EQT.

Pharmaceuticals & Biotechnology ShareCast News

Director dealings: Victoria non-exec invests, Fa... 13-Jan-2026 ShareCast
Revenues beat guidance at Oxford Nanopore, share... 12-Jan-2026 ShareCast
Haleon announces new chief growth officer role, ... 08-Jan-2026 ShareCast
Eden Research gets biopesticide label extension ... 07-Jan-2026 ShareCast
Aptamer shares slide despite revenue improvement 07-Jan-2026 ShareCast

Pharmaceuticals & Biotechnology Regulatory News

Form 8.3 - Oxford Biomedica plc 15-Jan-2026 09:21 RNS
Agronomics invests A$3m in All G & Issue of Equity 15-Jan-2026 07:00 RNS
Disclosure Table 14-Jan-2026 17:17 RNS
Response to press speculation 14-Jan-2026 16:49 RNS
Share Incentive Plan - Director/PDMR Shareholding 14-Jan-2026 16:00 RNS

Pharmaceuticals & Biotechnology Newspaper Links

Small companies roundup: Sinclair IS Pharma cons... 27-Nov-2014 Express & Star
MARKET REPORT: Buyers lining up for Sinclair sal... 26-Nov-2014 Daily Mail
Reneuron tests stem cell stroke treatment 03-Sep-2014 The Herald
AstraZeneca buys the rights to an asthma treatme... 13-Jun-2014 Daily Mail
AstraZeneca in new £138million asthma drug deal 13-Jun-2014 Express & Star

Pharmaceuticals & Biotechnology Tips & Analysis

Questor :GW Pharmaceuticals 04-Dec-2014 Telegraph
Questor : Hikma Pharmaceuticals 13-Mar-2014 Telegraph
Investment Column:BTG 06-Oct-2011 The Independent
Investment Column:Genus 09-Sep-2011 The Independent
Questor :Dechra Pharmaceuticals 08-Sep-2011 Telegraph

Pharmaceuticals & Biotechnology News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

Price Data

Price 26,449.37
Closing Price Change 519.76
% Change 2.00 %
14-Jan-26 Close 26,449.37

Top Risers

Price Change
CHLL 0.70p +16.7%
OXB 879.00p +9.3%
CIZ 1.63p +4.8%
IMM 7.44p +3.9%
AVCT 58.50p +2.6%
ONT 155.70p +2.1%
BVXP 1,775.00p +1.4%
HEMO 643.00p +1.1%
POLB 5.04p +1.0%
PRTC 136.20p +0.9%

Top Fallers

Price Change
AGY 10.86p -10.3%
PRM 3.00p -6.3%
VAL 0.36p -5.9%
OBI 7.69p -3.9%
APTA 0.94p -1.4%
SBTX 19.12p -1.3%
VRCI 0.74p -1.0%
STX 11.67p -0.7%
HLN 363.90p -0.6%
SVNS 0.29p -0.6%

Top of Page